Enanta Pharmaceuticals Inc Cash Flow Quality Index
Enanta Pharmaceuticals Inc cash flow quality index. Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Quality Index of 0.92x as of December 2019. Operating cash flow of $12.36 Million is below net income of $13.44 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Enanta Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Enanta Pharmaceuticals Inc (2010–2019)
Cash flow quality index of Enanta Pharmaceuticals Inc from 2010 to 2019. Historical Cash Flow Quality Index for Enanta Pharmaceuticals Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ENTA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Enanta Pharmaceuticals Inc Cash Flow Quality Index by Year (2010–2019)
Enanta Pharmaceuticals Inc cash flow quality index by year from 2010 to 2019. Year-by-year earnings quality comparison for Enanta Pharmaceuticals Inc. For the full cash flow conversion analysis, see Enanta Pharmaceuticals Inc (ENTA) cash conversion ratio.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 1.54x | $71.42 Million | $46.38 Million | ▲ +279.2% |
| 2018 | 0.41x | $29.22 Million | $71.96 Million | ▼ -86.3% |
| 2017 | 2.97x | $52.65 Million | $17.71 Million | ▲ +79.9% |
| 2016 | 1.65x | $35.81 Million | $21.67 Million | ▲ +70.3% |
| 2015 | 0.97x | $76.67 Million | $78.99 Million | ▲ +65.7% |
| 2014 | 0.59x | $20.18 Million | $34.44 Million | ▼ -47.0% |
| 2013 | 1.11x | $10.65 Million | $9.63 Million | ▲ +4.7% |
| 2012 | 1.06x | $22.62 Million | $21.40 Million | ▲ +2.6% |
| 2011 | 1.03x | $24.02 Million | $23.31 Million | ▲ +180.0% |
| 2010 | -1.29x | $-10.18 Million | $7.90 Million | — |